效应器
mTORC1型
细胞生物学
T细胞
PI3K/AKT/mTOR通路
CD8型
细胞毒性T细胞
糖酵解
生物
化学
信号转导
免疫学
抗原
免疫系统
生物化学
新陈代谢
体外
作者
Federica Agliano,Timofey Karginov,Antoine Ménoret,Anthony A. Provatas,Anthony T. Vella
出处
期刊:iScience
[Cell Press]
日期:2022-03-01
卷期号:25 (3): 103932-103932
被引量:5
标识
DOI:10.1016/j.isci.2022.103932
摘要
Nicotinamide (NAM) shapes T cell responses but its precise molecular mechanism of action remains elusive. Here, we show that NAM impairs naive T cell effector transition but also effector T cells themselves. Although aerobic glycolysis is a hallmark of activated T cells, CD8+ T cells exposed to NAM displayed enhanced glycolysis, yet producing significantly less IFNγ. Mechanistically, NAM reduced mTORC1 activity independently of NAD+ metabolism, decreasing IFNγ translation and regulating T cell transcriptional factors critical to effector/memory fate. Finally, the role of NAM in a biomedically relevant model of lung injury was tested. Specifically, a NAM-supplemented diet reduced systemic IL-2, antigen-specific T cell clonal expansion, and effector function after inhalation of Staphylococcus aureus enterotoxin A. These findings identify NAM as a potential therapeutic supplement that uncouples glycolysis from effector cytokine production and may be a powerful treatment for diseases associated with T cell hyperactivation.
科研通智能强力驱动
Strongly Powered by AbleSci AI